STERIS Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STERIS stock.
View analyst ratings for STERIS or view top-rated stocks.

Wall Street analysts have given STERIS a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STERIS wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

STERIS saw a increase in short interest in January. As of January 29th, there was short interest totaling 1,220,000 shares, an increase of 43.2% from the January 14th total of 851,700 shares. Based on an average daily volume of 452,600 shares, the short-interest ratio is presently 2.7 days.
View STERIS's Short Interest.

STERIS is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for STERIS.

STERIS plc (NYSE:STE) announced its quarterly earnings results on Tuesday, February, 2nd. The medical equipment provider reported $1.73 EPS for the quarter, topping analysts' consensus estimates of $1.52 by $0.21. The medical equipment provider earned $808.90 million during the quarter, compared to analyst estimates of $794.08 million. STERIS had a net margin of 13.97% and a trailing twelve-month return on equity of 14.44%. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.45 earnings per share.
View STERIS's earnings history.

STERIS's stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, STE stock has increased by 20.3% and is now trading at $174.80.
View which stocks have been most impacted by COVID-19.

STERIS announced a quarterly dividend on Tuesday, February 2nd. Stockholders of record on Wednesday, February 24th will be given a dividend of $0.40 per share on Thursday, March 25th. This represents a $1.60 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Tuesday, February 23rd.
View STERIS's dividend history.

STERIS pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.92%. STERIS has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of STERIS is 28.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STERIS will have a dividend payout ratio of 23.32% next year. This indicates that STERIS will be able to sustain or increase its dividend.
View STERIS's dividend history.

5 brokerages have issued 12 month price targets for STERIS's shares. Their forecasts range from $200.00 to $230.00. On average, they expect STERIS's share price to reach $213.50 in the next year. This suggests a possible upside of 22.1% from the stock's current price.
View analysts' price targets for STERIS or view top-rated stocks among Wall Street analysts.

196 employees have rated STERIS CEO Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among STERIS's employees.

Some companies that are related to STERIS include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and Varian Medical Systems (VAR).
View all of STE's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

STERIS's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.01%), WCM Investment Management LLC (7.72%), Janus Henderson Group PLC (3.81%), Northern Trust Corp (1.49%), William Blair Investment Management LLC (1.41%) and Select Equity Group L.P. (1.31%). Company insiders that own STERIS stock include Cary L Majors, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends for STERIS.

STE stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Select Equity Group L.P., Alta Capital Management LLC, Villere ST Denis J & Co. LLC, JPMorgan Chase & Co., Lazard Asset Management LLC, Nicholas Company Inc., and Frontier Capital Management Co. LLC. Company insiders that have sold STERIS company stock in the last year include Cary L Majors, Daniel A Carestio, David B Lewis, John Adam Zangerle, Julia Madsen, Karen L Burton, Mohsen Sohi, Richard C Breeden, and Walter M Rosebrough Jr.
View insider buying and selling activity for STERIS or view top insider-selling stocks.

STE stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., BlackRock Inc., Morgan Stanley, WCM Investment Management LLC, First Trust Advisors LP, Assenagon Asset Management S.A., Public Employees Retirement System of Ohio, and Clark Capital Management Group Inc..
View insider buying and selling activity for STERIS or or view top insider-buying stocks.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STE stock can currently be purchased for approximately $174.80.

STERIS has a market capitalization of $14.92 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis.

STERIS employs 13,000 workers across the globe.

The official website for STERIS is www.steris.com.

STERIS is headquartered at 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296.

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]